Average Co-Inventor Count = 1.86
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pimera, Inc. (11 from 11 patents)
2. Neurocrine Biosciences, Inc. (9 from 120 patents)
3. Cylene Pharmaceuticals, Inc. (5 from 21 patents)
4. Senhwa Biosciences, Inc. (3 from 11 patents)
5. Other (2 from 832,880 patents)
6. Panmira Pharmaceuticals, LLC (2 from 23 patents)
7. Amira Pharmaceuticals, Inc. (1 from 23 patents)
8. Revision Therapeutics, Inc. (1 from 1 patent)
34 patents:
1. 11912706 - Crystal forms of a POL1 inhibitor
2. 11866438 - Compositions, uses and methods for making them
3. 11623928 - Compositions, uses and methods for making them
4. 11618752 - Compositions, uses and methods for making them
5. 10975076 - Compositions, uses and methods for making them
6. 10745403 - Compositions, uses and methods for making them
7. 10590134 - Compositions, uses and methods for making them
8. 10442801 - Compositions, uses and methods for making them
9. 9951066 - Compositions, uses and methods for making them
10. 9758518 - Compositions, uses and methods for making them
11. 9512123 - Compositions, uses and methods for making them
12. 9303033 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
13. 8853234 - Quinolone analogs and methods related thereto
14. 8841295 - 5-lipoxygenase-activating protein (FLAP) inhibitors
15. 8575177 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors